Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 29 Jul 2025 | 50 | 14% | 48% | 38% | 0% |
| 01 Jul 2024 - 31 Dec 2024 | 31 Jan 2025 | 48 | 17% | 44% | 39% | 8% |
| 01 Jan 2024 - 30 Jun 2024 | 16 Jul 2024 | 43 | 26% | 47% | 27% | 4% |
| 01 Jul 2023 - 31 Dec 2023 | 19 Jan 2024 | 49 | 24% | 47% | 29% | 7% |
| 01 Jan 2023 - 30 Jun 2023 | 08 Aug 2023 | 53 | 18% | 46% | 36% | 16% |
| 01 Jul 2022 - 31 Dec 2022 | 30 Jan 2023 | 51 | 18% | 48% | 34% | 12% |
| 01 Jul 2021 - 31 Dec 2021 | 26 Jan 2022 | 49 | 21% | 49% | 30% | 7% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 49 | 28% | 49% | 24% | 11% |
| 01 Jul 2020 - 31 Dec 2020 | 20 Jan 2021 | 51 | 23% | 50% | 27% | 9% |
| 01 Jan 2020 - 30 Jun 2020 | 23 Jul 2020 | 46 | 32% | 48% | 20% | 8% |
| 01 Jul 2019 - 31 Dec 2019 | 27 Jan 2020 | 61 | 35% | 40% | 25% | 15% |
| 01 Jan 2019 - 30 Jun 2019 | 29 Jul 2019 | 34 | 44% | 34% | 21% | 34% |
| 01 Jul 2018 - 31 Dec 2018 | 30 Jan 2019 | 34 | 44% | 34% | 21% | 34% |
| 01 Jan 2018 - 30 Jun 2018 | 25 Jul 2018 | 35 | 41% | 32% | 27% | 36% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
UCB payment terms are 60 days for most vendors. Some vendors are paid on 30 days term.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Any disputes regarding payments are logged with our Account Payables Helpdesk. It will be raised with the payment team and cause and resolution will be investigated. if there is any escalation it will be referred to the local the local accounts payables team lead.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
UCB Pharma Limited is a UK pharmaceutical company registered in Slough, with a Companies House classification covering manufacture of basic pharmaceutical products. It is the entity behind the Zirtek brand, an antihistamine range sold in the UK for hayfever and year-round allergy relief, including tablets, children's liquid and an oral solution, all containing cetirizine dihydrochloride. Products address symptoms such as sneezing, congestion, itchy watery eyes and allergic skin rashes, with variants suited to different age groups from two years upwards. The company handles adverse event reporting for these medicines and provides consumer information and guidance on allergies through its website. It operates within the wider UCB pharmaceutical group.
Generated from the company's website and Companies House records. Sources: zirtek.co.uk · zirtek.co.uk · zirtek.co.uk